erythromycin base- erythromycin tablet, film coated
carilion materials management - erythromycin (unii: 63937kv33d) (erythromycin - unii:63937kv33d) - erythromycin 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin tablets, usp and other antibacterial drugs, erythromycin tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. erythromycin tablets, usp are indicated in the treatment of infections caused by susceptible strains of the designated microorganisms in the diseases listed below: upper respiratory tract infections of mild to moderate degree caused by streptococcus pyogenes ; streptococcus pneumoniae ; haemophilus influenzae (when used concomitantly with adequate doses of sulfonamides, since many strains of h. influenzae are not susceptible to the erythromycin concentrations
erythromycin tablet, film coated
a-s medication solutions - erythromycin (unii: 63937kv33d) (erythromycin - unii:63937kv33d) - erythromycin 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin tablets, usp and other antibacterial drugs, erythromycin tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. erythromycin tablets, usp are indicated in the treatment of infections caused by susceptible strains of the designated microorganisms in the diseases listed below: upper respiratory tract infections of mild to moderate degree caused by streptococcus pyogenes ; streptococcus pneumoniae ; haemophilus influenzae (when used concomitantly with adequate doses of sulfonamides, since many strains of h. influenzae are not susceptible to the erythromycin concentrations
erythromycin- erythromycin solution
e. fougera & co. - erythromycin (unii: 63937kv33d) (erythromycin - unii:63937kv33d) - solution - 20 mg - erythromycin pledgets, usp are indicated for the topical treatment of acne vulgaris. erythromycin pledgets, usp are contraindicated in those individuals who have shown hypersensitivity to any of its components.
erythromycin 250mg gastro-resistant tablets
a a h pharmaceuticals ltd - erythromycin - gastro-resistant tablet - 250mg
erythromycin 250mg gastro-resistant tablets
abbott laboratories ltd - erythromycin - gastro-resistant tablet - 250mg
erythromycin 250mg gastro-resistant tablets
accord-uk ltd - erythromycin - gastro-resistant tablet - 250mg
erythromycin 250mg gastro-resistant tablets
teva uk ltd - erythromycin - gastro-resistant tablet - 250mg
erythromycin 250mg gastro-resistant tablets
viatris uk healthcare ltd - erythromycin - gastro-resistant tablet - 250mg
erythromycin 250mg gastro-resistant tablets
ivax pharmaceuticals uk ltd - erythromycin - gastro-resistant tablet - 250mg
erythromycin 250mg gastro-resistant tablets
kent pharma (uk) ltd - erythromycin - gastro-resistant tablet - 250mg